Calidi Biotherapeutics Inc (CLDI)
0.236
0.00 (0.00%)
USD |
NYAM |
May 10, 16:00
0.2363
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics EPS Diluted (Quarterly): -0.2317 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.2317 |
September 30, 2023 | -0.14 |
December 31, 2022 | -0.216 |
Date | Value |
---|---|
September 30, 2022 | -0.1491 |
December 31, 2021 | -0.0972 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.2317
Minimum
Dec 2023
-0.0972
Maximum
Dec 2021
-0.1668
Average
-0.1491
Median
Sep 2022
EPS Diluted (Quarterly) Benchmarks
Minerva Neurosciences Inc | -1.13 |
Viking Therapeutics Inc | -0.26 |
CytomX Therapeutics Inc | 0.01 |
Genprex Inc | -3.76 |
Janux Therapeutics Inc | -0.24 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -8.229M |
Total Expenses (Quarterly) | 9.208M |
Enterprise Value | 9.305M |
Earnings Yield | -312.2% |